Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PRME · against 496 other Healthcare companies of similar size
Ranked #487 of 497 · scores higher than 2% of peers · safety percentile 2
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)44 peers with a safety percentile of 0–9, including PRME · Click a bar to see the companies
Mainly because of its beta and debt / equity, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PRME | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 465 reported | 2.83× | 0.18× | 3% | 33% | |
| BetaLower is better · 473 reported | 2.35 | 0.42 | 2% | 33% | |
| Current ratioHigher is better · 490 reported | 3.06× | 2.79× | 54% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 421M USD | 99 | 52 | |
| 483 | 1.2B USD | 4 | 6 | |
| 484 | 758M USD | 4 | 35 | |
| 485 | 487M USD | 3 | 29 | |
| 486 | 1.2B CHF (≈$1.4B) | 2 | 34 | |
| 487 | 825M USD | 2 | 24 | |
| 488 | 222.9B JPY (≈$1.5B) | 2 | 53 | |
| 489 | 1.2B CHF (≈$1.3B) | 1 | 28 | |
| 490 | 1.6B USD | 1 | 7 | |
| 491 | 1.3B USD | 1 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score